Skip to content

Confirming the impact on the urination frequency of "Immudyne URINUE"

Open test - Open test

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036172
Enrollment
7
Registered
2020-05-01
Start date
2019-04-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy person

Interventions

Take Immudyne URINUE for 4 weeks

Sponsors

IMMUDYNE INC.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)The person usually feeling that there is a lot of number of times of the urination and not taking one for treatment of a disease. 2)Applicants who voluntarily participate in clinical trials for men and women aged 20 and over and obtain written consent. 3)Those who can stop taking medicines and supplements that affect urination, health tea, etc. during the test period. 4)If you have not taken a supplement that is predicted to permanently affect urination within 1 month before the start of the study. 5)Those who can maintain a constant daily lifestyle during the examination period.

Exclusion criteria

Exclusion criteria: 1)If you have a serious disease (diabetes, heart disease, liver disease, kidney disease, cancer, etc.) or mental disease. 2)Patients who have a history of urinary diseases and surgery. 3)If you have 4 ng/ml or more of PSA measured in the pre-screening test. 4)Those who can not maintain daily living habits due to large changes in diet and exercise. 5)shift work, late work. 6)Possible food allergies or drug allergies to test food. 7)If you wish to have a pregnant woman, a nursing woman and a pregnancy during the examination period. 8)Others who are ineligible for examination by the investigator. 9)participants in other clinical trials within the past 1 month.

Design outcomes

Primary

MeasureTime frame
1) Safety: physiological test, biochemical test, hematology test 2) Usefulness: frequency of urination

Countries

Japan

Contacts

Public ContactEIICHIRO YAGI

IMMUDYNE INC. ACADEMIC AFFAIRS

e-yagi@immudyne.co.jp03-5467-6284

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026